Verbeek A - Search Results

1

Healthy donor effect: its magnitude in health research among blood donors.

Atsma F, Veldhuizen I, Verbeek A, de Kort W, de Vegt F. Atsma F, et al. Among authors: verbeek a. Transfusion. 2011 Aug;51(8):1820-8. doi: 10.1111/j.1537-2995.2010.03055.x. Epub 2011 Feb 22. Transfusion. 2011. PMID: 21342203

2

Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex.

Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA, Swinkels DW, Sweep FC, den Heijer M. Hoogendoorn EH, et al. Among authors: verbeek al. Clin Chem. 2006 Jan;52(1):104-11. doi: 10.1373/clinchem.2005.055194. Epub 2005 Oct 27. Clin Chem. 2006. PMID: 16254196 Free article.

3

Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis.

Ritoe SC, de Vegt F, Scheike IM, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, Marres HA. Ritoe SC, et al. Among authors: verbeek al. Cancer. 2007 Jan 15;109(2):239-47. doi: 10.1002/cncr.22401. Cancer. 2007. PMID: 17154185 Free article.

4

Fatigue and chronic fatigue syndrome-like complaints in the general population.

van't Leven M, Zielhuis GA, van der Meer JW, Verbeek AL, Bleijenberg G. van't Leven M, et al. Among authors: verbeek al. Eur J Public Health. 2010 Jun;20(3):251-7. doi: 10.1093/eurpub/ckp113. Epub 2009 Aug 18. Eur J Public Health. 2010. PMID: 19689970

5

No supportive evidence for clinical benefit of routine follow-up in ovarian cancer: a Dutch multicenter study.

Geurts SM, van Altena AM, de Vegt F, Tjan-Heijnen VC, Massuger LF, van Dijck JA, Verbeek AL. Geurts SM, et al. Among authors: verbeek al. Int J Gynecol Cancer. 2011 May;21(4):647-53. doi: 10.1097/IGC.0b013e318212b87d. Int J Gynecol Cancer. 2011. PMID: 21543930

6

Considering early detection of relapsed ovarian cancer: a review of the literature.

Geurts SM, de Vegt F, van Altena AM, van Dijck JA, Tjan-Heijnen VC, Verbeek AL, Massuger LF. Geurts SM, et al. Among authors: verbeek al. Int J Gynecol Cancer. 2011 Jul;21(5):837-45. doi: 10.1097/IGC.0b013e31821bb88c. Int J Gynecol Cancer. 2011. PMID: 21697678 Review.

7

[Aftercare in oncology--greater role for the general practitioner].

de Vegt F, van Dijck JA, van de Lisdonk EH, Verbeek AL. de Vegt F, et al. Among authors: verbeek al. Ned Tijdschr Geneeskd. 2011;155(45):A4148. Ned Tijdschr Geneeskd. 2011. PMID: 22085581 Dutch.

8

Impact of routine follow-up examinations on life expectancy in ovarian cancer patients: a simulation study.

Geurts SM, de Vegt F, van Altena AM, Tjan-Heijnen VC, Massuger LF, Adang EM, van Dijck JA, Verbeek AL. Geurts SM, et al. Among authors: verbeek al. Int J Gynecol Cancer. 2012 Sep;22(7):1150-7. doi: 10.1097/IGC.0b013e3182611451. Int J Gynecol Cancer. 2012. PMID: 22864333

9

The effect of frequent whole blood donation on ferritin, hepcidin, and subclinical atherosclerosis.

Peffer K, den Heijer M, Holewijn S, de Graaf J, Swinkels DW, Verbeek AL, Atsma F. Peffer K, et al. Transfusion. 2013 Jul;53(7):1468-74. doi: 10.1111/j.1537-2995.2012.03916.x. Epub 2012 Oct 9. Transfusion. 2013. PMID: 23043255

10

Pattern of follow-up care and early relapse detection in breast cancer patients.

Geurts SM, de Vegt F, Siesling S, Flobbe K, Aben KK, van der Heiden-van der Loo M, Verbeek AL, van Dijck JA, Tjan-Heijnen VC. Geurts SM, et al. Among authors: verbeek al. Breast Cancer Res Treat. 2012 Dec;136(3):859-68. doi: 10.1007/s10549-012-2297-9. Epub 2012 Nov 2. Breast Cancer Res Treat. 2012. PMID: 23117854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page